Cite
Venot Q, Blanc T, Rabia SH, et al. Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2019;568(7752):E6doi: 10.1038/s41586-019-1109-3.
Venot, Q., Blanc, T., Rabia, S. H., Berteloot, L., Ladraa, S., Duong, J. P., Blanc, E., Johnson, S. C., Hoguin, C., Boccara, O., Sarnacki, S., Boddaert, N., Pannier, S., Martinez, F., Magassa, S., Yamaguchi, J., Knebelmann, B., Merville, P., Grenier, N., Joly, D., Cormier-Daire, V., Michot, C., Bole-Feysot, C., Picard, A., Soupre, V., Lyonnet, S., Sadoine, J., Slimani, L., Chaussain, C., Laroche-Raynaud, C., Guibaud, L., Broissand, C., Amiel, J., Legendre, C., Terzi, F., & Canaud, G. (2019). Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature, 568(7752), E6. https://doi.org/10.1038/s41586-019-1109-3
Venot, Quitterie, et al. "Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome." Nature vol. 568,7752 (2019): E6. doi: https://doi.org/10.1038/s41586-019-1109-3
Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G. Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2019 Apr;568(7752):E6. doi: 10.1038/s41586-019-1109-3. PMID: 30944482.
Copy
Download .nbib